What was reported
Rejuvenate Bio filed a Form D with the SEC on Jun 18, 2026 and reported $19,471,354 sold of a $27,049,354 offering, with the first sale on Jun 3, 2026. 35 investors had invested.
What the evidence supports
Rejuvenate Bio told the SEC, in a notice filed Jun 18, 2026, that it had $19,471,354 of equity sold in an offering exempt from registration under Rule 506(b).
What remains unknown
A Form D is a notice: the SEC does not review or approve it. It does not state the company's valuation, the price paid, who invested, or how the money will be used, and the amount can span several closings. Rule 506(b) bars general advertising and limits buyers mainly to accredited investors. This record describes a past sale; it is not an offer, and it does not mean shares are available to buy.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $19,471,354 | “Total amount sold: $19,471,354” Mentions: offering |
| $27,049,354 | “Total offering amount: $27,049,354” Mentions: offering |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Amount sold to date (Form D; cumulative, not a valuation)Total amount sold: $19,471,354U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Total offering amount (Form D; the most the company said it would sell)Total offering amount: $27,049,354U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Form D noticeForm D: notice of exempt offering of securities, filed with the SEC on 2026-06-18 (accession 0001859067-26-000006)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Industry group as stated by the companyIndustry group (as stated by the issuer): BiotechnologyU.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Date of first sale (Form D)Date of first sale: 2026-06-03U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Investor count (Form D)Investors who have already invested: 35U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Exemption claimed (Form D)Exemption claimed: Rule 506(b)U.S. Securities and Exchange Commission (EDGAR) · Form D: notice of exempt offering of securities · Jun 18, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:52 UTC
Rejuvenate Bio reports $19.5 million of equity sold in a private offering
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.